Skip To Main Content
Robert Adamu Shey on Muck Rack

Robert Adamu Shey

As seen in: PLOS ONE, MDPI, BioRxiv, Cell Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Robert Adamu

Contact Robert Adamu, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Safety and immunogenicity of an adjuvanted human onchocerciasis vaccine candidate, OvMANE1: preclinical evaluation in mice model

|
By Derrick Neba Nebangwa, Cabirou Mounchili Shintouo, Robert Adamu Shey, Mary Teke Efeti
| BioRxiv
Abstract Onchocerciasis, caused by the filarial worm Onchocerca volvulus, remains a major public health challenge due to the limitations of ivermectin-based control strategies, thereby, highlighting the need for more innovative tools like vaccines. This study investigated the safety and immunogenicity of a novel multi-epitope chimeric antigen, OvMANE1 formulated with Freunds adjuvant, in BALB/c mice.
Open in Who Shared Issue with article?

One Health Approach to the Computational Design of a Lipoprotein-Based Multi-Epitope Vaccine Against Human and Livestock Tuberculosis

|
By Robert Adamu Shey, Cabirou Mounchili Shintouo, Gordon Takop Nchanji, Ntang Emmaculate Yaah
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Predictive immunoinformatics reveal promising safety and anti-onchocerciasis protective immune response profiles to vaccine candidates (Ov-RAL-2 and Ov-103) in anticipation of phase I clinical trials

|
By Derrick Neba Nebangwa, Robert Adamu Shey, Daniel Madulu Shadrack, Cabirou Mounchili Shintouo
| PLOS ONE
Loading metrics Open Access Peer-reviewed Research Article Citation: Nebangwa DN, Shey RA, Shadrack DM, Shintouo CM, Yaah NE, Yengo BN, et al. (2024) Predictive immunoinformatics reveal promising safety and anti-onchocerciasis protective immune response profiles to vaccine candidates (Ov-RAL-2 and Ov-103) in anticipation of phase I clinical trials. PLoS ONE 19(10): e0312315.
Open in Who Shared Issue with article?
See all 6 licensed articles (7 Total)